Research Open Access Hamdan Al-Jahdali, Siraj Wali, Amr S. Albanna, Riyad Allehebi, Hussein Al-Matar, Mohamed Fattouh & Maarten Beekman BMC Pulmonary Medicine volume 22, Article number: 67 (2022) Abstract Background Eosinophilia is a significant factor in asthma severity; however, the prevalence of…
Roland Buhl, MD, PhD Elisabeth Bel, MD, PhDArnaud Bourdin, MD, PhD Ignacio Dávila, MD, PhD Jo A. Douglass, MD J. Mark FitzGerald, MD David J. Jackson, MRCP, PhD Njira L. Lugogo,…
Wenliang Wu, Jiali Gao, Dian Chen, Gongqi Chen, Yuchen Feng, Chenli Chang, Shengchong Chen, Lingling Yi & Guohua Zhen Respiratory Research volume 23, Article number: 17 (2022) Abstract Background Type 2-high asthma is a prominent endotype of asthma which is characterized by airway eosinophilic…
Anchu Anna Cherian, Darshith Saragondlu Lakshminarasappa, Venkatesh Chandrasekaran, Palanivel Chinnakali https://doi.org/10.1002/hsr2.475 Abstract Background There is paucity of regional data regarding food allergy among children with asthma. Objectives To estimate the…
Research – Open Access Hiroaki Ogata, Katsuyuki Katahira, Aimi Enokizu-Ogawa, Yujiro Jingushi, Akiko Ishimatsu, Kazuhito Taguchi, Hiroko Nogami, Hiroshi Aso, Atsushi Moriwaki & Makoto Yoshida BMC Pulmonary Medicine volume 22, Article number: 22 (2022) Abstract Background Asthma–chronic obstructive pulmonary disease (COPD) overlap (ACO) patients…
Research – Open Access Min Li, Wenye Zhu, Ummair Saeed, Shibo Sun, Yan Fang, Chu Wang & Zhuang Luo BMC Pulmonary Medicine volume 22, Article number: 29 (2022) Abstract Background Asthma is a heterogeneous disease and different phenotypes based on clinical parameters…
Research Open Access Zhongping Wu, Ruibo Huang, Liping Zhong, Yi Gao & Jinping Zheng BMC Pulmonary Medicine volume 22, Article number: 23 (2022) Abstract Background The spirometer is an important element in lung function examinations, and its accuracy is directly…
Alyssa G. Burrows, BHScH Anne K. Ellis, MD, M.Sc. Ann Allergy Asthma Immunol. 2021 Dec 28:S1081-1206(21)01310-7. doi: 10.1016/j.anai.2021.12.013. Epub ahead of print. PMID: 34971763. With some exceptions, people with asthma…
Brian Park, PharmD The Food and Drug Administration (FDA) has approved Tezspire™ (tezepelumab-ekko) for the add-on maintenance treatment of patients 12 years of age and older with severe asthma. Tezspire…
Try a new quick-format CME activity on asthma with Dr. Michael Wechsler